Study drug | Dose and mode of administration |
---|
Capecitabine | 1000 mg/m2 per os twice daily as combined 150 mg and 500 mg tablets on days 1 to 14 of each 21-day cycle, followed by a 7-day resting period (i.e. off-treatment) |
Bevacizumab | 15 mg/kg intravenously once every 3 weeks (i.e. 5 mg/kg/week dose equivalent) |
Everolimus | 10 mg per os once daily of each 21-day cycle |
Exemestane | 25 mg per os once daily of each 21-day cycle |
- aDose and mode of administration of the study drugs were in accordance with current SmPC of respective study drug. Study drugs were available upon prescription by respective treating physician. A cycle was defined as 21 days of study treatment